drugset / Trial / NCT05219461
Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects
RandomizedParallel-groupDouble-blindScreening
Summary
A randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of the Pharmacokinetics, safety, and tolerability of rhEGF eye drops in healthy male subjects
Timeline
- Start
- 2019-03-29
- Primary completion
- 2019-11-13
- Completion
- 2019-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NEPIDERMIN | Protein / enzyme biologic | 10 ug/ml | Topical |
| Subject | NEPIDERMIN | Protein / enzyme biologic | 50 ug/ml | Topical |
| Subject | NEPIDERMIN | Protein / enzyme biologic | 100 ug/ml | Topical |